Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.
Deakin CT, Campanilho-Marques R, Simou S, Moraitis E, Wedderburn LR, Pullenayegum E, Pilkington CA; Juvenile Dermatomyositis Research Group. Deakin CT, et al. Among authors: pilkington ca. Arthritis Rheumatol. 2018 May;70(5):785-793. doi: 10.1002/art.40418. Epub 2018 Mar 25. Arthritis Rheumatol. 2018. PMID: 29342499 Free PMC article.
A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies.
Martin N, Krol P, Smith S, Murray K, Pilkington CA, Davidson JE, Wedderburn LR; Juvenile Dermatomyositis Research Group. Martin N, et al. Among authors: pilkington ca. Rheumatology (Oxford). 2011 Jan;50(1):137-45. doi: 10.1093/rheumatology/keq261. Epub 2010 Sep 7. Rheumatology (Oxford). 2011. PMID: 20823094 Free PMC article.
Comparison of children with onset of juvenile dermatomyositis symptoms before or after their fifth birthday in a UK and Ireland juvenile dermatomyositis cohort study.
Martin N, Krol P, Smith S, Beard L, Pilkington CA, Davidson J, Wedderburn LR; Juvenile Dermatomyositis Research Group (JDRG). Martin N, et al. Among authors: pilkington ca. Arthritis Care Res (Hoboken). 2012 Nov;64(11):1665-72. doi: 10.1002/acr.21753. Arthritis Care Res (Hoboken). 2012. PMID: 22674907 Free PMC article.
Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis.
Campanilho-Marques R, Almeida B, Deakin C, Arnold K, Gallot N, de Iorio M, Nistala K, Pilkington CA, Wedderburn LR; Juvenile Dermatomyositis Research Group. Campanilho-Marques R, et al. Among authors: pilkington ca. Arthritis Care Res (Hoboken). 2016 Oct;68(10):1514-21. doi: 10.1002/acr.22867. Epub 2016 Sep 16. Arthritis Care Res (Hoboken). 2016. PMID: 26881696 Free PMC article.
Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.
Deakin CT, Yasin SA, Simou S, Arnold KA, Tansley SL, Betteridge ZE, McHugh NJ, Varsani H, Holton JL, Jacques TS, Pilkington CA, Nistala K, Wedderburn LR; UK Juvenile Dermatomyositis Research Group. Deakin CT, et al. Among authors: pilkington ca. Arthritis Rheumatol. 2016 Nov;68(11):2806-2816. doi: 10.1002/art.39753. Epub 2016 Oct 9. Arthritis Rheumatol. 2016. PMID: 27214289 Free PMC article.
Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models.
Deakin CT, Papadopoulou C, McCann LJ, Martin N, Al-Obaidi M, Compeyrot-Lacassagne S, Pilkington CA, Tansley SL, McHugh NJ, Wedderburn LR, De Stavola BL; Juvenile Dermatomyositis Research Group. Deakin CT, et al. Among authors: pilkington ca. Rheumatology (Oxford). 2021 Apr 6;60(4):1891-1901. doi: 10.1093/rheumatology/keaa497. Rheumatology (Oxford). 2021. PMID: 33146389 Free PMC article.
46 results